{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Morph&page=5", "query": { "intervention": "Morph", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 1045, "total_pages": 105, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Morph&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Morph&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-25T11:31:01.980Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00560183", "title": "Efficacy and Safety of Q8003 in the Management of Post-bunionectomy Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postoperative Pain" ], "interventions": [ { "name": "Q8003 (morphine sulfate and oxycodone hydrochloride)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "QRxPharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 256, "start_date": "2007-11", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2012-05-17", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 6, "location_summary": "Anaheim, California • Pasadena, Maryland • Altoona, Pennsylvania + 2 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Pasadena", "state": "Maryland" }, { "city": "Altoona", "state": "Pennsylvania" }, { "city": "Houston", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00560183" }, { "nct_id": "NCT03579446", "title": "Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Hematopoietic and Lymphoid Cell Neoplasm", "Malignant Solid Neoplasm", "Metastatic Malignant Solid Neoplasm" ], "interventions": [ { "name": "Hydrocodone", "type": "DRUG" }, { "name": "Hydromorphone", "type": "DRUG" }, { "name": "Levorphanol", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Oxymorphone", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 43, "start_date": "2018-11-29", "completion_date": "2023-06-15", "has_results": false, "last_update_posted_date": "2025-08-03", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03579446" }, { "nct_id": "NCT03472469", "title": "MAST Trial: Multi-modal Analgesic Strategies in Trauma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Nonspecific Pain Post Traumatic Injury" ], "interventions": [ { "name": "Acetaminophen IV/PO", "type": "DRUG" }, { "name": "Acetaminophen PO", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Celebrex", "type": "DRUG" }, { "name": "Naproxen", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Opioids", "type": "DRUG" }, { "name": "Regional anesthesia", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 1561, "start_date": "2018-04-02", "completion_date": "2019-07-03", "has_results": true, "last_update_posted_date": "2021-06-18", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03472469" }, { "nct_id": "NCT02143141", "title": "Low Pain Prediction in Cesarean Section Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Scheduled Cesarean Sections", "Postoperative Pain Management", "Side Effects" ], "interventions": [ { "name": "duramorph", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 13, "start_date": "2011-11", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2018-09-10", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 1, "location_summary": "Winston-Salem, North Carolina", "locations": [ { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02143141" }, { "nct_id": "NCT01447888", "title": "Perioperative Pain Management In Spine Surgery Patients: Part I", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain" ], "interventions": [ { "name": "150% Oral Morphine Equivalent (OME)", "type": "DRUG" }, { "name": "Clinical Judgment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Allina Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2011-09", "completion_date": "2014-04", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01447888" }, { "nct_id": "NCT05429502", "title": "Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuroblastoma" ], "interventions": [ { "name": "Topotecan", "type": "DRUG" }, { "name": "Temozolomide", "type": "DRUG" }, { "name": "Ribociclib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "21 Years", "sex": "ALL", "summary": "12 Months to 21 Years" }, "enrollment_count": 12, "start_date": "2022-12-27", "completion_date": "2025-02-26", "has_results": false, "last_update_posted_date": "2025-10-10", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 3, "location_summary": "Boston, Massachusetts • New Hyde Park, New York • Memphis, Tennessee", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "New Hyde Park", "state": "New York" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05429502" }, { "nct_id": "NCT01185470", "title": "The Clinical Evaluation of Implantable Pump System For Safety And Delivery Accuracy In Patients Requiring Intrathecal Administration Of Morphine Sulfate For Chronic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Cancers", "Chronic Pain" ], "interventions": [ { "name": "Implantation of Morphine Sulfate delivering programmable pump", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medallion Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 75, "start_date": "2011-02", "completion_date": "2016-07", "has_results": false, "last_update_posted_date": "2017-04-24", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 9, "location_summary": "Scottsdale, Arizona • Carlsbad, California • La Jolla, California + 6 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Carlsbad", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Napa", "state": "California" }, { "city": "Bloomington", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01185470" }, { "nct_id": "NCT01364922", "title": "Phase 2 Chronic Low Back Pain Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Low Back Pain" ], "interventions": [ { "name": "hydrocodone/acetaminophen extended release", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie (prior sponsor, Abbott)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 168, "start_date": "2011-06", "completion_date": "2011-10", "has_results": true, "last_update_posted_date": "2014-01-29", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 17, "location_summary": "Tucson, Arizona • Anaheim, California • Burbank, California + 14 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Lomita", "state": "California" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01364922" }, { "nct_id": "NCT02469077", "title": "Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Pain" ], "interventions": [ { "name": "6 week aerobic exercise intervention", "type": "BEHAVIORAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Morphine", "type": "DRUG" }, { "name": "naloxone", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 117, "start_date": "2015-08", "completion_date": "2019-09", "has_results": true, "last_update_posted_date": "2020-09-23", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 2, "location_summary": "Chicago, Illinois • Nashville, Tennessee", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02469077" }, { "nct_id": "NCT00580151", "title": "The Use of Clonidine in Pain and Anxiety Associated With Acute Burn Injury in Children", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Anxiety" ], "interventions": [ { "name": "clonidine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Medical Branch, Galveston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "4 Years to 20 Years" }, "enrollment_count": 9, "start_date": "2004-06", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2015-02-23", "last_synced_at": "2026-10-25T11:31:01.980Z", "location_count": 1, "location_summary": "Galveston, Texas", "locations": [ { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00580151" } ] }